Clal Insurance Enterprises Holdings Ltd. (CLIS.TA)
Tel Aviv, IL
Clal Insurance Enterprises Holdings Ltd., an Israeli firm, delivers a comprehensive array of insurance solutions. Its business operations are structured into three main divisions: Long-Term Savings, Non-Life Insurance, and Health Insurance. The Long-Term Savings division provides life insurance products with associated coverages, various long-term savings programs, and manages pension and provident funds, including those designated for educational purposes. This segment also offers protection against risks such as mortality, impairment, loss of earning capacity, and diverse health-related circumstances. The Non-Life Insurance division encompasses policies for third-party, employer, professional, and product liabilities. It further covers credit and international trade exposures, property damage, vehicle protection, personal injury coverage, and other general insurance lines, alongside issuing guarantees. The Health Insurance division supplies policies for extended care, medical costs, surgical procedures, organ transplants, accidental injuries, international travel, dental services, coverage for foreign laborers, and other specific health protections. Clal Insurance Enterprises Holdings Ltd. was established in 1987 and maintains its headquarters in Tel Aviv-Yafo, Israel.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.53% | +0.07% | +11.05% | +21.17% | +46.33% | +37.72% | +145.28% | +436.35% | +322.84% | +537.35% | +434.53% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Diversified: +15.2%-43.6% Q1'26: +25.0% (vs Q1'25)
-
EPS growth Insurance - Diversified: +25.3%+204.3% ★ Q1'26: +5.4% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Diversified: +30.2%+77.0% ★ Q1'26: -20.4% (vs Q1'25)
-
EBIT margin Insurance - Diversified: +13.5%+28.1% ★ Q1'26: +20.7% (vs Q1'25)
-
ROIC Insurance - Diversified: +4.2%+11.9% ★ Q1'26: +10.7% (vs Q1'25)
-
Share dilution Insurance - Diversified: +0.0%+4.3% Q1'26: +1.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Diversified: -0.05×3.63× Q1'26: 4.61× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
15.13B
est: 8.75B (+72.9%)
|
9.22B
9.22B – 9.22B
+5.4% YoY
|
9.56B
9.56B – 9.56B
+3.6% YoY
|
9.90B
9.90B – 9.90B
+3.5% YoY
|
16.80B
16.80B – 16.80B
+69.8% YoY
|
17.25B
17.25B – 17.25B
+2.7% YoY
|
| EBITDA |
4.77B
est: 1.15B (+315.8%)
|
1.21B
1.21B – 1.21B
+5.4% YoY
|
1.25B
1.25B – 1.25B
+3.6% YoY
|
1.30B
1.30B – 1.30B
+3.5% YoY
|
2.20B
2.20B – 2.20B
+69.8% YoY
|
2.26B
2.26B – 2.26B
+2.7% YoY
|
| EBIT |
4.25B
est: 917.71M (+363.3%)
|
967.61M
967.61M – 967.61M
+5.4% YoY
|
1.00B
1.00B – 1.00B
+3.6% YoY
|
1.04B
1.04B – 1.04B
+3.5% YoY
|
1.76B
1.76B – 1.76B
+69.8% YoY
|
1.81B
1.81B – 1.81B
+2.7% YoY
|
| Net Income |
2.28B
est: 2.27B (+0.2%)
|
2.27B
2.27B – 2.27B
-0.2% YoY
|
2.40B
2.40B – 2.40B
+5.5% YoY
|
2.53B
2.53B – 2.53B
+5.5% YoY
|
2.67B
2.67B – 2.67B
+5.5% YoY
|
2.81B
2.81B – 2.81B
+5.5% YoY
|
| SGA |
—
est: 394.94M (-100.0%)
|
416.42M
416.42M – 416.42M
+5.4% YoY
|
431.37M
431.37M – 431.37M
+3.6% YoY
|
446.69M
446.69M – 446.69M
+3.5% YoY
|
758.48M
758.48M – 758.48M
+69.8% YoY
|
778.65M
778.65M – 778.65M
+2.7% YoY
|
| EPS |
28.57
est: 27.43 (+4.2%)
|
27.38
27.38 – 27.38
-0.2% YoY
|
28.90
28.90 – 28.90
+5.5% YoY
|
30.48
30.48 – 30.48
+5.5% YoY
|
32.15
32.15 – 32.15
+5.5% YoY
|
33.92
33.92 – 33.92
+5.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | B+ | 3/5 | 4/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-05-01 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 5/5 | 4/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-15 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sagit Dotan | CEO of Max | 5M | female |
| Yoram Naveh | Chief Executive Officer | 3M | male |
| Eran Cherninsky | Executive Vice President, Chief Financial Officer & Head of Finance Division | 3M | male |
| Moshe Arnst | Deputy Chief Executive Officer & Chief Executive Officer of Clal Pension & Provident Funds | 2M | male |
| Barak Benski | Deputy CEO, EVP of Investment Manager & Head of the Investment Division | — | male |
| Shlomi Tamman | Deputy Chief Executive Officer & Agents Manager | — | male |
| Tal Cohen | Senior Vice President & Chief Accounting Division Manager | — | male |
| Liat Strauss | Deputy Chief Executive Officer and Director of Service, Human Resources & Operations | — | female |
| Dror Biran | Deputy Chief Executive Officer & General Counsel | — | male |
| Dror Sessler | Deputy Chief Executive Officer & Director of Claims | — | male |
| Galli Schved | Executive Vice President of Marketing and Strategy Unit Manager of Clal Insurance | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CLIS.TA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
